- Published
- Updated
Which observations remain necessary after treatment stops depends on the effect the trial targets. Leaving this question until analysis can mean essential outcomes were never collected. Plan information needs together with participant preferences and continued permission.
Define the question and assumptions
Consider treatment continuation, visit participation and permission for particular data types separately. Establish a process explaining follow-up options without pressuring participants. Define which measurements are needed, when they are collected, whether mode can change and how they relate to the protocol question before operational teams begin implementation.
Hypothetical study example
In a hypothetical trial, a person stops study treatment but agrees to a short endpoint assessment. The team checks whether this option fits the protocol and consent scope. It neither assumes that stopping treatment ends every contact nor continues data collection the person has declined.
Design review checks
- Record treatment cessation separately from permission for continued data collection.
- Evaluate minimum necessary endpoint follow-up options prospectively within the protocol.
- Document reasons for unavailable observations and the agreed limits of contact.
Record the decision and its limits
An accepted plan lets operational staff explain which information is needed and why. Make the role of post-discontinuation outcomes explicit in missing-data assessment. Continued follow-up respects participant rights and applicable permission conditions; statistical needs do not replace the participant decision and cannot justify promises of complete data regardless of circumstances.
Frequently asked questions
- Are all observations unnecessary after treatment stops?
- No. The target treatment-effect question may require subsequent outcomes.
- Can continued follow-up be made compulsory?
- Participant rights, preferences and valid permission conditions must be respected.